Like Eli Lilly, Viking Therapeutics' Oral Weight Loss Drug Disappoints, Stock TanksBenzinga • 08/19/25
2 Phenomenal Dividend Growth Stocks That Insiders Are Buying Hand Over Fist24/7 Wall Street • 08/18/25
Enterprise Software Extinction Via AI Exaggerated, Their Stocks Becoming Incredibly CheapSeeking Alpha • 08/18/25
This Healthcare Stock's Bad News Could Create a $10 Billion Opportunity for CompetitorsThe Motley Fool • 08/17/25
Eli Lilly Vs. Novo Nordisk: Correction Overly Done - GLP-1 Market Leadership/ Robust Pipelines AheadSeeking Alpha • 08/16/25
Novo Nordisk's Lead Fades, Eli Lilly Holds Course For Outsized Gains, Says AnalystBenzinga • 08/15/25
Eli Lilly signs $1.3 billion deal with Superluminal to use AI to make obesity medicinesFast Company • 08/15/25
Eli Lilly said it is in talks to raise drug prices in Europe, starting with weight-loss drug Mounjaro in the U.K., so it can meet President Trump's goal of bringing down prices in the U.S.WSJ • 08/14/25
Eli Lilly Hikes UK Mounjaro Price By Up To 170% As Trump Pressure MountsInvestors Business Daily • 08/14/25
Eli Lilly hikes price of diabetes drug Mounjaro in UK as Trump pressures pharma to align drug costsCNBC • 08/14/25
Lanier Law Firm Representing Health Choice Alliance in Litigation Alleging Eli Lilly Offered Kickbacks to Texas Health Care ProvidersBusiness Wire • 08/14/25